FIELD: pharmacology.
SUBSTANCE: invention relates to 3-(azol-1-yl)-6-amino substituted 1,2,4,5-tetrazines of the formula: , where Het = imidazol-1-yl, NHR = allylamino (Ia); Het = 4-methylimidazol-1-yl, NHR = allylamino (Ib); Het = benzimidazol-1-yl, NHR = allylamino (Ic); Het = indazol-1-yl, NHR = allylamino (Id); Het = imidazol-1-yl, NHR = propargylamino (Ie); Het = 4-methylimidazol-1-yl, NHR = propargylamino (If); Het = benzimidazol-1-yl, NHR = propargylamino (Ig); Het = indazol-1-yl, NHR = propargylamino (Ih). The invention also relates to antibacterial agents.
EFFECT: new compounds of formula I, active against gram-negative bacteria Neisseria gonorrhoeae and clinically relevant pathogenic and opportunistic microorganisms, are obtained.
2 cl, 2 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
3-ISOPROPOXY-6-R-IMIDAZO[1,2-B][1,2,4,5]TETRAZINES HAVING ANTIBACTERIAL ACTIVITY AGAINST NEISSERIA GONORRHOEAE | 2020 |
|
RU2767869C1 |
3-GUANIDINO-6-R-TRIAZOLO[4,3-B][1,2,4,5]TETRAZINES WITH ANTIBACTERIAL ACTIVITY | 2018 |
|
RU2663890C1 |
4-ISOPROPYL-6-R-IMIDAZO[1,2-B][1,2,4,5]TETRAZIN-3(4H)- ES WITH ANTIBACTERIAL ACTIVITY AGAINST NEISSERIA GONORRHOEAE | 2020 |
|
RU2754554C1 |
6-SUBSTITUTED 3-AZOLYLIMIDAZO[1,2-b][1,2,4,5]TETRAZINES SHOWING ANTICANCER ACTIVITY | 2013 |
|
RU2527258C1 |
ANTI-TUBERCULOSIS AGENTS BEING 3,7-DISUBSTITUTED [1,2,4]TRIAZOLO[1,5-b][1,2,4,5]TETRAZINES | 2022 |
|
RU2802300C1 |
SELECTIVE ANTI-TUBERCULOSIS AGENTS, REPRESENTING 3-AMINOSUBSTITUTED 6-(3,5-DIMETHYLPYRAZOL-1-YL)-1,2,4,5-TETRAZINES | 2012 |
|
RU2519218C2 |
3-GUANIDINOAZOLO[1,2,4,5]TETRAZINES HAVING ANTIGLYCATING ACTIVITY AND A PROCESS FOR THEIR PREPARATION | 2017 |
|
RU2668971C1 |
SUBSTITUTED AZOLO[1,2,4,5]TETRAZINES - INHIBITORS OF ANTIBACTERIAL SERINE-THREONINE PROTEIN KINASES | 2011 |
|
RU2462466C1 |
N-ARYL-4-(5-NITROFURAN-2-YL)-PYRIMIDINE-5-AMINES WITH ANTIBACTERIAL ACTIVITY AND METHOD FOR THEIR OBTAINING | 2017 |
|
RU2642428C1 |
BIS[1,2,4]TRIAZOLO[4,3-b:3',4'-f][1,2,4,5]TETRAZINES WITH ANTI-GLYCATING, ANTI-GLYCOXIDATION AND ANTIPLATELET ACTIVITY | 2020 |
|
RU2755897C1 |
Authors
Dates
2018-01-30—Published
2017-01-27—Filed